Short answer
Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results covered three months ended March 31, 2026.
Surgery Partners, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results covered three months ended March 31, 2026
- Press release issued May 5, 2026; detailed financial results and outlook in Exhibit 99.1
- Non-GAAP measures included with GAAP reconciliations for assessing operating performance
- Disclosure furnished under Regulation FD, limiting Section 18 liability and incorporation by reference
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $810.9M, up 4.5%, driven by 4.4% same-facility growth and 3.8% higher revenue per case
- Same-facility cases rose 0.6%, while total cases fell to 157,711 from 160,300, signaling growth relies on pricing and mix
- Adjusted EBITDA declined to $102.3M from $103.9M, with margin compressing to 12.6% from 13.4%
- Net loss attributable to Surgery Partners improved to $35.9M from $37.7M, but adjusted loss widened to $4.1M from $5.4M profit
- 2026 guidance reaffirmed: revenue $3.35B–$3.45B and Adjusted EBITDA at least $530M; net leverage approximately 4.3x 天天买彩票
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Surgery Partners, Inc. 8-K filings
Get the next SGRY 8-K as it lands
Follow SGRY for push alerts, or ask the research agent what this filing means.